Short description
Xycrobe Therapeutics is an early-stage biotechnology company that helps develop novel therapies for clinical applications.
Description
Xycrobe Therapeutics is an early-stage biotechnology company that aims to leverage an extensive amount of data being generated from human microbiome research to develop novel therapies for clinical applications. The company develops innovations that take advantage of the nature of microbes by turning it into vehicles for the delivery of biotherapeutics. The company's goal is to create better solutions for clinical indications, focusing on inflammatory skin diseases.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
La Jolla, California, United States, North America
Founded on
January 1, 2014
Exited on
May 22, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Founders
Thomas M. Hitchcock